A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors
Clinical trial NCT00999401 · COMPLETED
Trial details
- NCT number
- NCT00999401
- Sponsor
- Cyclacel Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2019-07-16
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.